Page last updated: 2024-08-24

atorvastatin and HIV

atorvastatin has been researched along with HIV in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Di Santo, R	1
Jimenez, VC; Norris, KA; Outwater, JA; Rabacal, W; Rayens, E; Schweitzer, F; Tarantelli, R; Whang, P	1
Christenson, R; deFilippi, C; Fitch, KV; Grinspoon, SK; Hoffmann, U; Joyce, J; Lo, J; Looby, SE; Lu, MT; Park, EA; Wu, A	1

Trials

1 trial(s) available for atorvastatin and HIV

Article	Year
Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV. Journal of acquired immune deficiency syndromes (1999), 2018, 05-01, Volume: 78, Issue:1 Topics: Adolescent; Adult; Amino Acids; Atorvastatin; Biomarkers; Blood Proteins; Coronary Artery Disease; Double-Blind Method; Female; Fibrosis; Galectin 3; Galectins; Growth Differentiation Factor 15; HIV; HIV Infections; Humans; Inflammation; Interleukin-1 Receptor-Like 1 Protein; Interleukin-6; Lipoproteins, LDL; Male; Middle Aged; Receptors, Interleukin-1; Young Adult	2018

Article

Year

Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV.

Journal of acquired immune deficiency syndromes (1999), 2018, 05-01, Volume: 78, Issue:1

Topics: Adolescent; Adult; Amino Acids; Atorvastatin; Biomarkers; Blood Proteins; Coronary Artery Disease; Double-Blind Method; Female; Fibrosis; Galectin 3; Galectins; Growth Differentiation Factor 15; HIV; HIV Infections; Humans; Inflammation; Interleukin-1 Receptor-Like 1 Protein; Interleukin-6; Lipoproteins, LDL; Male; Middle Aged; Receptors, Interleukin-1; Young Adult

2018

Other Studies

2 other study(ies) available for atorvastatin and HIV

Article	Year
Inhibiting the HIV integration process: past, present, and the future. Journal of medicinal chemistry, 2014, Feb-13, Volume: 57, Issue:3 Topics: Allosteric Regulation; Animals; Catalytic Domain; Drug Resistance, Viral; Enzyme Activators; Genetic Therapy; HIV; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; Humans; Models, Molecular; Protein Conformation; Protein Multimerization; Virus Integration	2014
Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH. Scientific reports, 2019, 12-27, Volume: 9, Issue:1 Topics: Animals; Atorvastatin; Disease Models, Animal; HIV; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macaca mulatta; Macrophages, Alveolar; Monocytes; Pulmonary Arterial Hypertension; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load	2019

Article

Year

Inhibiting the HIV integration process: past, present, and the future.

Journal of medicinal chemistry, 2014, Feb-13, Volume: 57, Issue:3

Topics: Allosteric Regulation; Animals; Catalytic Domain; Drug Resistance, Viral; Enzyme Activators; Genetic Therapy; HIV; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; Humans; Models, Molecular; Protein Conformation; Protein Multimerization; Virus Integration

2014

Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH.

Scientific reports, 2019, 12-27, Volume: 9, Issue:1

Topics: Animals; Atorvastatin; Disease Models, Animal; HIV; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macaca mulatta; Macrophages, Alveolar; Monocytes; Pulmonary Arterial Hypertension; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load

2019